BRPI0816465A2 - Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol - Google Patents

Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol

Info

Publication number
BRPI0816465A2
BRPI0816465A2 BRPI0816465A BRPI0816465A2 BR PI0816465 A2 BRPI0816465 A2 BR PI0816465A2 BR PI0816465 A BRPI0816465 A BR PI0816465A BR PI0816465 A2 BRPI0816465 A2 BR PI0816465A2
Authority
BR
Brazil
Prior art keywords
cholecalciferol
administration
treating
methods
respiratory tract
Prior art date
Application number
Other languages
English (en)
Inventor
Jefffrey Warren Clymer
Paul John Rennie
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0816465A2 publication Critical patent/BRPI0816465A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0816465 2007-09-04 2008-09-04 Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol BRPI0816465A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96741207P 2007-09-04 2007-09-04
PCT/US2008/075197 WO2009032887A1 (en) 2007-09-04 2008-09-04 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol

Publications (1)

Publication Number Publication Date
BRPI0816465A2 true BRPI0816465A2 (pt) 2015-03-24

Family

ID=40090141

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0816465 BRPI0816465A2 (pt) 2007-09-04 2008-09-04 Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol
BRPI0816350-2A2A BRPI0816350A2 (pt) 2007-09-04 2008-09-04 Composições orais, produtos e métodos de uso

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0816350-2A2A BRPI0816350A2 (pt) 2007-09-04 2008-09-04 Composições orais, produtos e métodos de uso

Country Status (9)

Country Link
US (2) US20090060879A1 (pt)
EP (2) EP2194990A2 (pt)
CN (2) CN101801389A (pt)
AU (2) AU2008296311B2 (pt)
BR (2) BRPI0816465A2 (pt)
CA (2) CA2698514A1 (pt)
MX (2) MX2010002498A (pt)
RU (2) RU2479313C2 (pt)
WO (2) WO2009032888A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178106B2 (en) * 2009-03-30 2012-05-15 Mary Kay Inc. Topical skin care formulations
WO2013026557A1 (de) * 2011-08-19 2013-02-28 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Vasokonstriktorhaltiges kombinationstherapeutikum
WO2013052101A1 (en) * 2011-10-03 2013-04-11 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130101634A1 (en) * 2011-10-12 2013-04-25 Deerland Enzymes, Inc. Compositions and methods for reducing microbial overgrowth in the small intestines
JP6092126B2 (ja) * 2012-02-10 2017-03-08 Ｍｃフードスペシャリティーズ株式会社 アムラ由来成分含有果実系飲食品
US20130273182A1 (en) * 2012-04-12 2013-10-17 Po-Lun Wang A Herbal Extract for Treating Fatty Liver Disease and a Medication Thereof
US9616124B2 (en) * 2014-07-17 2017-04-11 Jonathan S. Nimitz Antiviral supplement compositions and methods of use
WO2016037166A1 (en) * 2014-09-07 2016-03-10 Yu Zhang Novel anti-oxidant compositions and methods of delivery
WO2016195526A1 (ru) * 2015-06-03 2016-12-08 Людмила Борисовна ТИМИРОВА Успокаивающая композиция, понижающая возбудимость при половой охоте у кошек и собак
DE102016105369A1 (de) * 2016-03-22 2017-09-28 Bernd Büter Erzeugnis, insbesondere Nahrungsmittelzusatz, Futtermittel oder Tierfutterzusatz und Verfahren zu dessen Herstellung
US20210368843A1 (en) * 2016-08-04 2021-12-02 Seattle Gummy Company Mineral compositions and methods of making and using thereof
WO2018169497A1 (en) * 2017-03-17 2018-09-20 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
WO2018227146A1 (en) * 2017-06-08 2018-12-13 Allergyintellect, Inc Vitamin d compounds and methods of using the same
CN108813608A (zh) * 2018-05-25 2018-11-16 陕西黄龙国寿堂生物工程有限公司 一种沙棘刺五加膏的制作方法
CN109549993A (zh) * 2018-12-29 2019-04-02 西安高科陕西金方药业公司 直肠或雾化吸入给药射干抗病毒制剂和制备及用途
CN110051758A (zh) * 2019-05-20 2019-07-26 西安高科陕西金方药业公司 一种射干抗病毒口服制剂及其制备方法
DE102019218199A1 (de) * 2019-11-25 2021-05-27 Sternenzym Gmbh & Co. Kg Verfahren zum Behandeln von Kaffeebohnen, sowie Kaffeebohne, die gemäß diesem Verfahren hergestellt wurde
WO2021180973A1 (en) * 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
WO2022006446A1 (en) * 2020-07-02 2022-01-06 The Uab Research Foundation Compositions and methods of treating conditions
IT202000018949A1 (it) * 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali
IT202100010409A1 (it) * 2021-04-23 2022-10-23 Esserre Pharma Srl Composizione comprendente un fitocomplesso da melograno e suoi usi
CN115154502B (zh) * 2022-08-02 2023-11-03 黑龙江乌苏里江制药有限公司 一种抗炎组合物及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
RU2033160C1 (ru) * 1991-04-08 1995-04-20 Апуховская Лариса Ивановна Способ производства витамина d3 -белкового препарата "видеин"
GB9203535D0 (en) * 1992-02-19 1992-04-08 Leo Pharm Prod Ltd Novel treatment iii
US6187764B1 (en) * 1997-05-05 2001-02-13 Angelina Pinal Buttz A and D vitamins and their metabolites: A new treatment for seasonal allergic rhinitis and atopy
GB0016173D0 (en) * 2000-06-30 2000-08-23 Nestle Sa Confectionery product containing active ingredients
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
JP2005518381A (ja) * 2001-12-19 2005-06-23 ザ キグリー コーポレーション 抹消神経・血管疾患の治療方法
US6572903B1 (en) * 2002-05-08 2003-06-03 4 Seasons Wildlife Nutrition, Llc Wildlife nutritional supplement
AU2004207720A1 (en) * 2003-01-31 2004-08-12 Teijin Pharma Limited Crystal of (23S)-1alpha-hydroxy-27-nor-25-methylenevitamin D3-26,23-lactone and process for producing the same
RU2241437C1 (ru) * 2003-04-28 2004-12-10 Открытое акционерное общество "Косметическое объединение "Свобода" Зубная паста "пародонтол" с экстрактом зеленого чая, фтором, витаминами а и е
KR20040101695A (ko) * 2003-05-26 2004-12-03 (주)헬스마스터 산모용 특수영양식품
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
JP2005239694A (ja) * 2004-02-27 2005-09-08 Taiyo Kagaku Co Ltd 抗ストレス組成物
US20050260285A1 (en) * 2004-05-21 2005-11-24 Dimateeo-Leggio Giovina Healthy prostate formula
WO2006048457A1 (en) * 2004-11-05 2006-05-11 Dsm Ip Assets B.V. Probiotica and polyphenol
RU2290943C2 (ru) * 2004-12-20 2007-01-10 Дмитрий Николаевич Мясников Композиция, обладающая тонизирующим действием
US7442394B2 (en) * 2005-05-02 2008-10-28 University Of South Florida Combined effects of nutrients on proliferation of stem cells
WO2006130971A1 (en) * 2005-06-07 2006-12-14 Vivabody Formulations Ltd. Diet supplement for weight loss, energy and improved mental focus
EP1945185B1 (en) * 2005-10-12 2016-02-03 Proventiv Therapeutics, LLC Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
EP1962614B1 (en) * 2005-11-25 2010-08-04 DSM IP Assets B.V. Use of 25-hydroxy vitamin d3 to improve vitality of animals
EP1891944A1 (en) * 2006-07-24 2008-02-27 Association pour la recherche à l'IGBMC (ARI) Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases
KR101959952B1 (ko) * 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US8318708B2 (en) * 2007-11-06 2012-11-27 Salk Institute For Biological Studies Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis

Also Published As

Publication number Publication date
MX2010002410A (es) 2010-03-26
RU2010105123A (ru) 2011-10-20
EP2194990A2 (en) 2010-06-16
WO2009032888A3 (en) 2009-12-03
US20090060878A1 (en) 2009-03-05
US20090060879A1 (en) 2009-03-05
BRPI0816350A2 (pt) 2015-02-24
AU2008296311B2 (en) 2014-07-03
RU2479316C2 (ru) 2013-04-20
EP2194989A1 (en) 2010-06-16
CA2698517A1 (en) 2009-03-12
CA2698514A1 (en) 2009-03-12
AU2008296310A1 (en) 2009-03-12
RU2010105122A (ru) 2011-10-10
WO2009032888A2 (en) 2009-03-12
MX2010002498A (es) 2010-03-26
CN101801389A (zh) 2010-08-11
AU2008296311A1 (en) 2009-03-12
CN101795693A (zh) 2010-08-04
WO2009032887A1 (en) 2009-03-12
RU2479313C2 (ru) 2013-04-20

Similar Documents

Publication Publication Date Title
BRPI0816465A2 (pt) Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol
BRPI0817872A2 (pt) sistema para tratamento de um paciente que apresenta um distúrbio intestinal.
BRPI0817384A2 (pt) "método para a fabricação de um dispositivo, dispositivo para inalação e dispositivo ou componente"
BRPI0917894A2 (pt) composição de múltiplas camadas para máscara respiratória
BRPI0818109A2 (pt) corpo de máscara para meia-máscara respirátoria
BRPI0818958A2 (pt) "processos para a fabricação dos hidrofluoroalquenos, para a fabricação dos hidrofluoroalcanóis, para a fabricação dos hidrofluoroésteres e composto"
BRPI0815682A2 (pt) dispositivo para isolamento de respiração de paciente, sistema para compartimento de venilador, e, métodos para compartilhar um único ventilador por pelo menos dois pacientes e para melhorar o desempenho de um ventilador.
BRPI0716696A2 (pt) Sistema de aplicação para tratamento remoto de um animal
BRPI0819755A2 (pt) composto, composição farmacêutica, processos para a preparação de um composto e de uma composição farmacêutica, uso de um composto, e, método para tratar ou reduzir o risco de uma doença ou uma condição inflamatória
IL213825A0 (en) Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
BRPI0817968A2 (pt) Sistema de umidificação respiratória
BRPI0819020A2 (pt) "método e sistema para criar uma peça"
BRPI0916039A2 (pt) "sistema para extrair secreções das vias aéreas de um indivíduo"
BRPI0814957A2 (pt) Composto, pró-droga, agente farmacêutico, método para a profilaxia ou tratamento de uma doença, distúrbio ou condição, e, uso do composto.
BRPI0916102A2 (pt) "método para a prevenção da hérnia paraestomal, método para preparar uma hérnia paraestomal e dispositivo para preparar ou reduzir a incidência da hérnia paraestomal"
BRPI0920847A2 (pt) composto, formulação farmacêutica, e, método para o tratamento, prevenção ou retardo na progressão de câncer em um paciente
BRPI1013396A2 (pt) composto, produto farmacêutico de combinação, uso de um composto, método para tratar uma doença ou condição, e, processo para a preparação de um composto.
BRPI0815591A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
HK1145141A1 (en) Mipo inhibitors for the treatment of huntington's disease and multiple system atrophy
CL2013001565A1 (es) Metodo para tratar la ingesta excesiva o comer compulsivamente, que comprende el uso de bupropion y naltrexona y la composicion farmaceutica que comprende a ambos compuestos.
BRPI0809601A2 (pt) Método para fabricar composto, composição para o tratamento ou a prevenção da influenza, e, composto
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
BR112014003118A2 (pt) composto que induz atividade de cardiotrofina-1 (ct-1) para uso na prevenção e/ou tratamento de lesão renal aguda, composição e uso de uma composição
EP2123300A4 (en) MEDICAL AGENT FOR THE TREATMENT OF BIRD FLUID
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.